F. Domont

3.3k total citations
34 papers, 1.2k citations indexed

About

F. Domont is a scholar working on Ophthalmology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. Domont has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 14 papers in Rheumatology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. Domont's work include Ocular Diseases and Behçet’s Syndrome (14 papers), Vasculitis and related conditions (10 papers) and Systemic Lupus Erythematosus Research (9 papers). F. Domont is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (14 papers), Vasculitis and related conditions (10 papers) and Systemic Lupus Erythematosus Research (9 papers). F. Domont collaborates with scholars based in France, Belgium and Tunisia. F. Domont's co-authors include P. Cacoub, David Saadoun, Cloé Comarmond, Léa Savey, A.C. Desbois, Bahram Bodaghi, Yasmina Ferfar, D. Sène, Fabien Koskas and Marlène Garrido and has published in prestigious journals such as Annals of Internal Medicine, The American Journal of Medicine and Ophthalmology.

In The Last Decade

F. Domont

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Domont France 16 405 403 306 266 266 34 1.2k
A.C. Desbois France 26 690 1.7× 556 1.4× 543 1.8× 457 1.7× 647 2.4× 57 1.9k
Léa Savey France 15 330 0.8× 288 0.7× 235 0.8× 60 0.2× 231 0.9× 50 1.1k
R. Pérez-Álvarez Spain 19 488 1.2× 599 1.5× 343 1.1× 45 0.2× 164 0.6× 25 1.6k
Maria Letizia Urban Italy 21 348 0.9× 611 1.5× 110 0.4× 142 0.5× 38 0.1× 53 1.1k
Cloé Comarmond France 26 1.1k 2.8× 853 2.1× 677 2.2× 222 0.8× 857 3.2× 59 2.5k
Karim Sacré France 26 531 1.3× 881 2.2× 288 0.9× 128 0.5× 37 0.1× 116 2.1k
F. Maurier France 20 458 1.1× 751 1.9× 303 1.0× 63 0.2× 31 0.1× 57 1.3k
Cándido Díaz‐Lagares Spain 19 277 0.7× 704 1.7× 346 1.1× 25 0.1× 261 1.0× 25 1.5k
Ayşe Çefle Türkiye 17 198 0.5× 492 1.2× 92 0.3× 216 0.8× 29 0.1× 94 1.0k
Soledad Retamozo Spain 22 318 0.8× 475 1.2× 378 1.2× 23 0.1× 286 1.1× 55 1.7k

Countries citing papers authored by F. Domont

Since Specialization
Citations

This map shows the geographic impact of F. Domont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Domont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Domont more than expected).

Fields of papers citing papers by F. Domont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Domont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Domont. The network helps show where F. Domont may publish in the future.

Co-authorship network of co-authors of F. Domont

This figure shows the co-authorship network connecting the top 25 collaborators of F. Domont. A scholar is included among the top collaborators of F. Domont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Domont. F. Domont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sève, P., Georgina Maalouf, Laurent Kodjikian, et al.. (2025). Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis Uveitis. Ophthalmology. 132(10). 1125–1133.
2.
Leclercq, Mathilde, P. Sève, Lucie Biard, et al.. (2024). Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. British Journal of Ophthalmology. 109(1). 34–40. 2 indexed citations
3.
Desbois, A.C., F. Domont, Amine Ghembaza, et al.. (2023). Behçet’s Disease Uveitis. Journal of Clinical Medicine. 12(11). 3648–3648. 3 indexed citations
4.
Desbois, A.C., F. Domont, Amine Ghembaza, et al.. (2023). Behçet's disease uveitis. La Revue de Médecine Interne. 44(10). 546–554. 1 indexed citations
5.
Ferfar, Yasmina, Olivier Espitia, C. Agard, et al.. (2021). Spectrum and Outcome of Noninfectious Aortitis. The Journal of Rheumatology. 48(10). 1583–1588. 4 indexed citations
6.
Benhadou, Farida, Violette Dirix, F. Domont, et al.. (2021). Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment. Frontiers in Immunology. 12. 672894–672894. 4 indexed citations
7.
Leclercq, Mathilde, Georgina Maalouf, P. Sève, et al.. (2021). Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema. Ophthalmology. 129(5). 520–529. 45 indexed citations
8.
Comarmond, C., Mathilde Leclercq, Gaëlle Leroux, et al.. (2020). 2019 Novel Coronavirus Disease (COVID-19) in Patients with Large-Vessels Vasculitis: Single-centre Experience in Paris. HAL (Le Centre pour la Communication Scientifique Directe). 72. 2–2. 1 indexed citations
9.
Saadoun, David, Amine Ghembaza, Sébastien Rivière, et al.. (2020). Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study. Journal of Autoimmunity. 116. 102577–102577. 15 indexed citations
10.
Peiffer‐Smadja, Nathan, F. Domont, David Saadoun, & P. Cacoub. (2019). Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis. Autoimmunity Reviews. 18(6). 621–626. 15 indexed citations
11.
Joncour, Alexandre Le, Stéphane Loyau, Antoine Dossier, et al.. (2019). Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease. Annals of the Rheumatic Diseases. 78(9). 1274–1282. 111 indexed citations
12.
Ferfar, Yasmina, Léa Savey, Cloé Comarmond, et al.. (2017). Large-vessel vasculitis in human immunodeficiency virus-infected patients. Journal of Vascular Surgery. 67(5). 1501–1511. 17 indexed citations
13.
Chapelon, C., Lucie Biard, F. Domont, et al.. (2017). Severe infections in sarcoidosis. Medicine. 96(49). e8846–e8846. 36 indexed citations
14.
Mirouse, Adrien, Stéphane Barète, J.‐B. Monfort, et al.. (2017). Ustekinumab for Behçet's disease. Journal of Autoimmunity. 82. 41–46. 51 indexed citations
15.
Bertrand, Anne, Frédéric Clarençon, S. Gerber, et al.. (2016). Neuroimaging features in posterior reversible encephalopathy syndrome: A pictorial review. Journal of the Neurological Sciences. 373. 188–200. 51 indexed citations
16.
Mirouse, Adrien, Léa Savey, F. Domont, et al.. (2016). Systemic vasculitis associated with vemurafenib treatment. Medicine. 95(46). e4988–e4988. 8 indexed citations
17.
Ferfar, Yasmina, Tristan Mirault, A.C. Desbois, et al.. (2016). Biotherapies in large vessel vasculitis. Autoimmunity Reviews. 15(6). 544–551. 36 indexed citations
18.
Cacoub, P., Cloé Comarmond, F. Domont, Léa Savey, & David Saadoun. (2015). Cryoglobulinemia Vasculitis. The American Journal of Medicine. 128(9). 950–955. 162 indexed citations
20.
Wyndham-Thomas, Chloé, Véronique Corbière, Violette Dirix, et al.. (2014). Key Role of Effector Memory CD4+T Lymphocytes in a Short-Incubation Heparin-Binding Hemagglutinin Gamma Interferon Release Assay for the Detection of Latent Tuberculosis. Clinical and Vaccine Immunology. 21(3). 321–328. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026